FilingFirehose · free AI preview
Vivos Therapeutics, Inc.
VVOS · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 2
Types: Delisting
Vivos Therapeutics (VVOS) filed two delisting notices within the past 90 days, with the most recent in June 2026 citing multiple disclosure items including officer departures and material agreements. This signals acute going-concern risk that requires immediate context—what triggered the delisting notices, what financing or restructuring is underway, and whether equity holders face material dilution. The full $49 Report adds delisting timeline analysis, 12-month financing history, officer departure details, and AI-driven equity dilution risk scoring to quantify downside exposure.
Want the full 5-section $49 Report on VVOS?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.